[Endovascular brachytherapy to prevent restenosis after angioplasty].
Endovascular radiotherapy is the first effective prophylaxis of restenosis after percutaneous transluminal angioplasty (PTA) and stenting. The FDA recently approved two devices for the delivery of intracoronary radiation following coronary artery stenting. Published multicenter, double-blind, randomized trials of intracoronary radiation therapy report good results for preventing in-stent restenosis, while the data for the peripheral circulation are still inconclusive. Beta-emitters are easier applicable and probably also safer, whereas gamma-emitters have been more extensively evaluated clinically so far. Primary indication for endovascular brachytherapy are patients at high risk for restenosis, such as previous restenoses, in-stent hyperplasia, long stented segment, long PTA lesion, narrow residual vascular lumen and diabetes. Data from coronary circulation suggest a safety margin of at least 4 to 10 mm at both ends of the angioplastic segment to avoid edge restenosis. To prevent late thrombosis of the treated coronary segment, antiplatelet therapy with clopidogrel and aspirin are recommended for at least 6 months after PTA and for 12 months after a newly implanted stent. An established medication regimen after radiotherapy of peripheral arteries is still lacking.
Wohlgemuth
W A
WA
Klinik für Diagnostische Radiologie und Neuroradiologie, Klinikum Augsburg. w.wohlegemuth@online.de
Bohndorf
K
K
D000800:Angioplasty, Balloon / Q000295:instrumentation*; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D001157:Arterial Occlusive Diseases / Q000532:radiotherapy*; D001241:Aspirin / Q000008:administration & dosage; D001918:Brachytherapy / Q000295:instrumentation*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D003131:Combined Modality Therapy; D023903:Coronary Restenosis / Q000532:radiotherapy*; D005500:Follow-Up Studies; D006801:Humans; D019233:Retreatment; D015607:Stents; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives
D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin